North America Veterinary Healthcare Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis

The North America Veterinary Healthcare Market is projected to grow significantly, reaching an estimated US$ 64,615.4 million by 2031, up from US$ 37,968.7 million in 2024. This growth represents a compound annual growth rate (CAGR) of 8.0% from 2025 to 2031.

### Executive Summary and Market Analysis
The veterinary healthcare market in North America is primarily divided into three key regions: the United States, Canada, and Mexico. The United States dominates the market, holding the largest share, followed by Canada. The increasing demand for veterinary healthcare services in the region is driven by several factors, including enhanced government support aimed at providing affordable healthcare services and strategic initiatives by major veterinary healthcare companies such as Elanco, Zoetis Inc., and Boehringer Ingelheim Animal Health USA, Inc. These companies are actively working to improve veterinary products and services, which is crucial for the market's expansion.

### Strategic Insights
#### Market Segmentation

The North America Veterinary Healthcare Market is segmented based on various criteria:

• **By Animal Type**: The market is divided into Companion Animals and Livestock & Poultry, with Livestock & Poultry holding the largest market share in 2024.
• **By Companion Animal Type**: This segment includes Dogs, Cats, and Others, where Dogs accounted for the largest share in 2024.
• **By Livestock and Poultry**: This includes Poultry, Equine, Bovine, and Others, with Poultry again leading the market share in 2024.
• **By Product Type**: The market is categorized into Pharmaceuticals, Medical Devices, and Feed Additives, with Pharmaceuticals dominating in 2024.
• **By Pharmaceuticals Products**: This includes Antimicrobials, Parasiticides, Vaccines, and Others, where the 'Others' category held the largest share in 2024.
• **By End User**: The market is segmented into Veterinary Hospitals, Clinics, and Others, with Veterinary Hospitals leading in market share in 2024.

### Market Outlook
The rise in zoonotic diseases, which are diseases that can be transmitted from animals to humans, is a significant factor influencing the veterinary healthcare market. According to the Centers for Disease Control and Prevention (CDC), over 60% of infectious diseases in humans are zoonotic, and 75% of emerging infectious diseases originate from animals. Each year, zoonotic diseases result in approximately 2.5 billion human infections and 2.7 million deaths globally. The World Organization for Animal Health (WOAH) reports that around 60% of pathogens responsible for human diseases come from domestic animals or wildlife, and 80% of bioterrorism-related pathogens are animal-derived.

Common zoonotic diseases include Ebola, rabies, salmonella, anthrax, Lyme disease, E. coli, and bird flu. The World Health Organization (WHO) indicates that animal diseases contribute to over 20% of global production losses in livestock, which poses a threat to the livelihoods of rural communities reliant on animal agriculture. The increasing incidence of zoonotic diseases is driving demand for preventive measures, such as vaccinations and diagnostic tests, thereby boosting the emphasis on animal healthcare products and services. Pet owners and farmers are increasingly focused on protecting their animals to safeguard human health, which in turn propels market growth.

### Country Insights
The North America Veterinary Healthcare Market is further analyzed by country, with the United States holding the largest market share in 2024. The surge in pet ownership in the U.S. is a key driver for the demand for veterinary medications and vaccines for companion animals. According to the 2023-2024 American Pet Products Association Survey, 66% of U.S. households, equating to approximately 86.9 million households, own a pet. Additionally, the increasing number of product approvals by the U.S. Food and Drug Administration (FDA) is contributing to market demand. For instance, in September 2024, the FDA approved Zenrelia, a once-daily oral JAK inhibitor for managing pruritus associated with allergic dermatitis in dogs.

In October 2023, Zoetis launched two FDA-approved drugs in the U.S. veterinary market, including bedinvetmab injection (Librela) for controlling pain associated with osteoarthritis in dogs, marking a significant advancement in veterinary medicine. These developments highlight the ongoing innovation and expansion within the veterinary healthcare sector.

### Key Players
The North America Veterinary Healthcare Market features several prominent players, including Merck & Co., Inc., Boehringer Ingelheim International GmbH, Ceva Santé Animale, Zoetis Inc., Elanco Animal Health Inc., Idexx Laboratories Inc., Neogen Corp, HIPRA SA, Shenzhen Mindray Animal Medical Technology Co., LTD, and Antech Diagnostics, Inc. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions to consumers.